These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23536670)

  • 1. Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.
    Nixon B; Stefanidou M; Mesquita PM; Fakioglu E; Segarra T; Rohan L; Halford W; Palmer KE; Herold BC
    J Virol; 2013 Jun; 87(11):6257-69. PubMed ID: 23536670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.
    Nixon B; Jandl T; Teller RS; Taneva E; Wang Y; Nagaraja U; Kiser PF; Herold BC
    Antimicrob Agents Chemother; 2014; 58(2):1153-60. PubMed ID: 24323471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
    Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a Dual-Target, Safe, Inexpensive Microbicide that Protects Against HIV-1 and HSV-2 Disease.
    Farr Zuend C; Nomellini JF; Smit J; Horwitz MS
    Sci Rep; 2018 Feb; 8(1):2786. PubMed ID: 29434285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.
    Hayashi K; Onoue H; Sasaki K; Lee JB; Kumar PK; Gopinath SC; Maitani Y; Kai T; Hayashi T
    Arch Virol; 2014 Mar; 159(3):425-35. PubMed ID: 24046087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
    Marrazzo JM; Rabe L; Kelly C; Richardson B; Deal C; Schwartz JL; Chirenje ZM; Piper J; Morrow RA; Hendrix CW; Marzinke MA; Hillier SL;
    J Infect Dis; 2019 May; 219(12):1940-1947. PubMed ID: 30753642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
    Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
    Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
    Wilson SS; Cheshenko N; Fakioglu E; Mesquita PM; Keller MJ; Herold BC
    Antivir Ther; 2009; 14(8):1113-24. PubMed ID: 20032541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
    Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
    Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracts of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2.
    Churqui MP; Lind L; Thörn K; Svensson A; Savolainen O; Aranda KT; Eriksson K
    J Ethnopharmacol; 2018 Jan; 210():192-197. PubMed ID: 28807852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.
    Derby N; Lal M; Aravantinou M; Kizima L; Barnable P; Rodriguez A; Lai M; Wesenberg A; Ugaonkar S; Levendosky K; Mizenina O; Kleinbeck K; Lifson JD; Peet MM; Lloyd Z; Benson M; Heneine W; O'Keefe BR; Robbiani M; Martinelli E; Grasperge B; Blanchard J; Gettie A; Teleshova N; Fernández-Romero JA; Zydowsky TM
    Nat Commun; 2018 Sep; 9(1):3881. PubMed ID: 30250170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
    Hayashi K; Hayashi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.
    Ali MM; Karasneh GA; Jarding MJ; Tiwari V; Shukla D
    J Virol; 2012 Jun; 86(12):6434-43. PubMed ID: 22491462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
    Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
    Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
    Awasthi S; Huang J; Shaw C; Friedman HM
    J Virol; 2014 Aug; 88(15):8421-32. PubMed ID: 24829358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.
    Thurman AR; Doncel GF
    Int J STD AIDS; 2012 Sep; 23(9):613-9. PubMed ID: 23033511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.